NEXENTIS TECHNOLOGIES INC. Increase (Decrease) in Prepaid Expense and Other Assets
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$393.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-13
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$439.00K.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $46.00K.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$95.00K.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $113.00K.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$66.00K.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$262.00K.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$165.00K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$439.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$393.00K 10-Q · filed 2026-08-13 | -$488.00K derived: sum of 3 quarters · filed 2026-08-13 | -$375.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | $46.00K 10-Q · filed 2026-05-14 | -$49.00K derived: sum of 2 quarters · filed 2026-05-14 | $64.00K derived: sum of 3 quarters · filed 2026-05-14 | $3.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | -$95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $18.00K derived: sum of 2 quarters · filed 2026-03-31 | -$43.00K derived: sum of 3 quarters · filed 2026-08-13 | -$66.00K 10-K · filed 2026-03-31 | |||
| 2025-09-30 | $113.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $52.00K derived: sum of 2 quarters · filed 2026-08-13 | $29.00K 10-Q · filed 2025-11-13 | -$79.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | -$61.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$84.00K 10-Q · filed 2026-08-13 | -$192.00K derived: sum of 3 quarters · filed 2026-08-13 | -$332.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | -$23.00K 10-Q · filed 2026-05-14 | -$131.00K derived: sum of 2 quarters · filed 2026-05-14 | -$271.00K derived: sum of 3 quarters · filed 2026-05-14 | -$199.00K derived: sum of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | -$108.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$248.00K derived: sum of 2 quarters · filed 2026-03-31 | -$176.00K derived: sum of 3 quarters · filed 2026-03-31 | -$262.00K 10-K · filed 2026-03-31 | |||
| 2024-09-30 | -$140.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$68.00K derived: sum of 2 quarters · filed 2025-11-13 | -$154.00K 10-Q · filed 2025-11-13 | -$153.77K 10-Q · filed 2024-11-14 | -$196.06K derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $72.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$14.00K 10-Q · filed 2025-08-14 | -$13.62K 10-Q · filed 2024-08-14 | -$56.06K derived: sum of 3 quarters · filed 2025-08-14 | -$117.28K derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | -$86.00K 10-Q · filed 2025-05-15 | -$86.60K 10-Q · filed 2024-05-15 | -$128.06K derived: sum of 2 quarters · filed 2025-05-15 | -$189.28K derived: sum of 3 quarters · filed 2025-05-15 | -$266.98K derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | -$42.06K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$103.28K derived: sum of 2 quarters · filed 2025-03-31 | -$180.98K derived: sum of 3 quarters · filed 2025-03-31 | -$165.00K 10-K · filed 2025-03-31 | |||
| 2023-09-30 | -$61.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$138.91K derived: sum of 2 quarters · filed 2024-11-14 | -$122.94K 10-Q · filed 2024-11-14 | ||||
| 2023-06-30 | -$77.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$61.73K 10-Q · filed 2024-08-14 | |||||
| 2023-03-31 | $15.98K 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |